FDA ISSUES FINAL GUIDANCE ABOUT MULTIPLE ENDPOINTS IN CLINICAL TRIALS

Clinical Regulatory Clinical Trial Design FDA FDA Guidance

Critical Considerations to Advance Gene Therapy Products for Rare Diseases

Regulatory Gene Therapy Health Authority Meetings rare disease

A Change in Course: FDA Requires Randomized Data to Support PI3K Inhibitor Approvals in Hematologic Malignancies

Data Regulatory

The Launch of the BGTC

Regulatory BGTC Cell and Gene Therapy FDA